To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof
H4050 would create a comprehensive state regulatory system for adult use of psilocybin-containing fungi in Massachusetts. It establishes a new chapter in the General Laws governing psilocybin permits for adults 18 and older, a required health screening and education course, optional support services, personal cultivation, and licensed commercial cultivation, testing, labeling, and distribution. The bill also creates a regulated psilocybin advisory board within the Department of Public Health to oversee implementation, develop standards and educational materials, determine exclusion criteria, and advise on public health and safety issues.
The bill is structured as a public health framework rather than a medical legalization measure. It expressly states that psilocybin use under the chapter is not intended to diagnose, treat, cure, or prevent disease, while still allowing permit holders to access psilocybin for adult use after completing screening and education requirements. It sets limits on where use may occur, restricts sales to permit holders, allows noncommercial gifting between permit holders, and authorizes licensed cultivators to sell directly to permit holders within an intrastate system. It also provides protections for permit holders, cultivators, healthcare providers, caregivers, and certified support services providers from arrest, prosecution, professional discipline, and related penalties for conduct authorized by the chapter.
The bill would also amend existing controlled substances law by excluding psilocybin and psilocin from certain scheduling provisions in chapter 94C, effectively carving them out from the state’s controlled substances framework to the extent needed for the new regulated system. It creates tax credits for certain licensed cultivators and for individuals or small business enterprises engaged in existing fungi cultivation activities, including some people with criminal records related to psilocybin possession or cultivation. The bill further directs tax treatment of revenue from psilocybin-related activities, allows deductions for business expenses, and dedicates proceeds and fees to administration, public education, and subsidized support services and therapy for low-income participants.
The overall sentiment reflected by the bill text is strongly supportive of regulated access, harm reduction, and equity-based implementation. Although there were no committee transcripts or recorded votes provided, the proposal’s structure emphasizes safety, education, public health oversight, low-income fee waivers, subsidized support services, and opportunities for participation by people with prior criminal records or existing agricultural experience. The bill also highlights indigenous, cultural, and therapeutic contexts for psilocybin, suggesting an intent to frame the policy as both health-oriented and access-oriented.
The main points of contention likely concern public safety, the scope of adult access, and the relationship between state authorization and federal controlled substances law. The bill addresses these concerns by requiring screening, excluding certain health conditions, limiting public use near schools, and preserving employer and federal-law protections where necessary. Potentially controversial features include allowing self-reported health screening, permitting direct sales and home cultivation, creating a new market for support services, and using tax revenue to subsidize psilocybin-related services. The bill also leaves significant rulemaking authority to the Department of Public Health and the advisory board, which could become a focus of debate over implementation and oversight.
If enacted, H4050 would add a new chapter to the Massachusetts General Laws establishing a regulated adult-use psilocybin system and would amend the state controlled substances schedule to exclude psilocybin and psilocin from specified prohibitions. It would also create new tax credits in chapters 62 and 63, establish tax treatment for psilocybin-related income and expenses, and direct the Department of Public Health to promulgate regulations, certify providers, license cultivators, and administer permit and reporting systems. The bill would affect adults seeking psilocybin permits, licensed cultivators, support services providers, healthcare professionals, law enforcement, employers, and low-income participants, while also creating record-sealing opportunities for prior psilocybin offenses.
The bill’s overall tone is favorable toward legalization through regulation, with a strong emphasis on public health, education, harm reduction, and equitable access. Even without recorded debate or votes, the text suggests a reform-oriented approach that seeks to normalize psilocybin use under state oversight rather than criminal enforcement. The inclusion of fee waivers, subsidies, and protections for participants and providers indicates a generally supportive policy posture toward access and implementation.
Likely areas of contention include whether psilocybin should be legalized for adult use at all, whether the permit system and self-reporting model provide enough safeguards, and whether the Department of Public Health should have broad discretion to define exclusion criteria and regulations. Opponents may also object to home cultivation, direct-to-consumer sales, and protections that limit professional or criminal penalties, while supporters are likely to emphasize the bill’s screening requirements, age limits, public-use restrictions, and public-health framing. Federal law conflict, workplace impairment, and the use of public funds or tax revenue to subsidize psilocybin services are additional likely flashpoints.